On Invalid Date, Bioaffinity Technologies (NASDAQ: BIAF) reported Q3 2023 earnings per share (EPS) of -$0.26, up 77.78% year over year. Total Bioaffinity Technologies earnings for the quarter were -$2.29 million. In the same quarter last year, Bioaffinity Technologies's earnings per share (EPS) was -$1.17.
As of Q4 2023, Bioaffinity Technologies's earnings has grown year over year. Bioaffinity Technologies's earnings in the past year totalled -$7.24 million.
What was BIAF's revenue last quarter?
On Invalid Date, Bioaffinity Technologies (NASDAQ: BIAF) reported Q3 2023 revenue of $298.48 thousand up 25,855.13% year over year. In the same quarter last year, Bioaffinity Technologies's revenue was $1.15 thousand.
What was BIAF's revenue growth in the past year?
As of Q4 2023, Bioaffinity Technologies's revenue has grown 12,989.94% year over year. This is 12,989.24 percentage points higher than the US Diagnostics & Research industry revenue growth rate of 0.7%. Bioaffinity Technologies's revenue in the past year totalled $321.49 thousand.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.